Courtney, Rachel
Memorial Sloan Kettering Cancer Center · The Barbara Ann Karmanos Cancer Institute · University of Pennsylvania
2 papers on CoChat
Most cited papers
- Verified
Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer
Flaherty, K. T., LoRusso, P. M., DeMichele, A., Abramson, V. G., Courtney, R., Randolph, S. S., Shaik, M. N., Wilner, K. D., O'Dwyer, P. J., & Schwartz, G. K. (2012) · Clinical Cancer Research
Advanced Breast Cancer TherapiesCancer-related Molecular Pathways
Cited by 366
- Verified
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
Leonard, J. P., LaCasce, A. S., Smith, M. R., Noy, A., Chirieac, L. R., Rodig, S. J., Yu, J. Q., Vallabhajosula, S., Schoder, H., English, P., et al. (2012) · Blood
Lymphoma Diagnosis and TreatmentAdvanced Breast Cancer Therapies
Cited by 299
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free